These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 5969039)

  • 1. Anabolic agents. 19-Nor- and 19-substituted 5alpha-androst-2-ene derivatives.
    Counsell RE; Adelstein GW
    J Med Chem; 1966 Sep; 9(5):685-9. PubMed ID: 5969039
    [No Abstract]   [Full Text] [Related]  

  • 2. Anabolic agents. 2,3-Epithioandrostane derivatives.
    Klimstra PD; Nutting EF; Counsell RE
    J Med Chem; 1966 Sep; 9(5):693-7. PubMed ID: 5969041
    [No Abstract]   [Full Text] [Related]  

  • 3. [2-formyl-11-alpha-hydroxy-delta 1-methyltestosterone: a new anabolic water-soluble steroid].
    Gomarasca M
    Minerva Med; 1971 Feb; 62(17):842-5. PubMed ID: 5102562
    [No Abstract]   [Full Text] [Related]  

  • 4. Anabolic agents. A-ring oxygenated androstane derivatives.
    Klimstra PD; Zigman R; Counsell RE
    J Med Chem; 1966 Nov; 9(6):924-9. PubMed ID: 5972054
    [No Abstract]   [Full Text] [Related]  

  • 5. New classes of orally active hormonal derivatives. 1. Alkyl androstan-17beta-YL and alkyl 19-norandrostan-17beta-YL mixed acetals.
    Vitali R; Gardi R; Falconi G; Ercoli A
    Steroids; 1966 Oct; 8(4):527-36. PubMed ID: 5972513
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative androgenic, myotrophic and antigonadotrophic properties of some anabolic steroids.
    Boris A; Stevenson RH; Trmal T
    Steroids; 1970 Jan; 15(1):61-71. PubMed ID: 5410669
    [No Abstract]   [Full Text] [Related]  

  • 7. Anabolic-androgenic activity of A-ring modified androstane derivatives. II. A comparison of oral activity.
    Nutting EF; Klimstra PD; Counsell RE
    Acta Endocrinol (Copenh); 1966 Dec; 53(4):635-43. PubMed ID: 5953689
    [No Abstract]   [Full Text] [Related]  

  • 8. [Anabolic activity of 9, 10-dehydro-19-nortestosterone derivatives].
    Ivanenko TI; Shishkina AA; Rzheznikov VM; Pivnitskiĭ KK
    Probl Endokrinol (Mosk); 1974; 20(4):83-8. PubMed ID: 4453568
    [No Abstract]   [Full Text] [Related]  

  • 9. Anabolic-androgenic activity of A-ring modified androstane derivatives. I. A comparison of parenteral activity.
    Nutting EF; Klimstra PD; Counsell RE
    Acta Endocrinol (Copenh); 1966 Dec; 53(4):627-34. PubMed ID: 6012541
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experimental study of the anabolic activity of 6-ketoderivatives of certain natural sapogenins].
    Syrov VN; Kurmukov AG
    Farmakol Toksikol; 1976; 39(5):631-5. PubMed ID: 1028596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estradienes and 2-oxaestradienes. Potent oral anabolic-androgenic agents.
    Nutting EF; Calhoun DW
    Endocrinology; 1969 Feb; 84(2):441-2. PubMed ID: 5764313
    [No Abstract]   [Full Text] [Related]  

  • 12. 17beta-hydroxy-5alpha-androst-1-en-3-one (1-testosterone) is a potent androgen with anabolic properties.
    Friedel A; Geyer H; Kamber M; Laudenbach-Leschowsky U; Schänzer W; Thevis M; Vollmer G; Zierau O; Diel P
    Toxicol Lett; 2006 Aug; 165(2):149-55. PubMed ID: 16621347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and anabolic/androgenic evaluation of novel 9alpha-fluorosteroids.
    Reyes-Moreno M; Ruiz-García JA; Ibarra-Reyes Y; Fuente-Hernández A; Vélez-Castro H; Hernández-Balmaseda I; Martínez-Hormaza I; Rodeiro-Guerra I; Ramírez JS; Reyes SM; Montiel-Smith S
    Eur J Med Chem; 2009 Nov; 44(11):4567-71. PubMed ID: 19615789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anabolic-androgenic steroids and aggression in castrated male rats.
    Clark AS; Barber DM
    Physiol Behav; 1994 Nov; 56(5):1107-13. PubMed ID: 7824579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and myotrophic-androgenic activity of 17beta-hydroxy-5alpha-androst-8(14)-en-3-one derivatives.
    Wolff ME; Chang HH
    J Med Chem; 1970 Sep; 13(5):967-8. PubMed ID: 5458391
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacological and toxicological properties of 19-nortestosterone-homofarnesta (DA 1979), a new anabolic agent.
    Coppi G; Gaetani M; Bonardi G
    Arzneimittelforschung; 1973 May; 23(5):693-700. PubMed ID: 4740213
    [No Abstract]   [Full Text] [Related]  

  • 17. [New steroids with high myotropic-androgenic related effects].
    Dörner G; Grychtolik H; Hüttenrauch R; Schubert A
    Acta Biol Med Ger; 1966; 16(3):323-5. PubMed ID: 5987023
    [No Abstract]   [Full Text] [Related]  

  • 18. Dissociation of anabolic and androgenic properties of steroids by anti-anabolic and anti-androgenic agents in rats.
    Steinetz BG; Giannina T; Butler M; Popick
    Endocrinology; 1971 Sep; 89(3):894-6. PubMed ID: 5566400
    [No Abstract]   [Full Text] [Related]  

  • 19. The biological activity of 7 alpha-methyl-19-nortestosterone is not amplified in male reproductive tract as is that of testosterone.
    Kumar N; Didolkar AK; Monder C; Bardin CW; Sundaram K
    Endocrinology; 1992 Jun; 130(6):3677-83. PubMed ID: 1597164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of growth hormone in the anabolic action of methandrostenolone.
    Steinetz BG; Giannina T; Butler M; Popick F
    Endocrinology; 1972 May; 90(5):1396-8. PubMed ID: 5012751
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.